GEN-CLOZAPINE Tablets 25 mg Australia - English - Department of Health (Therapeutic Goods Administration)

gen-clozapine tablets 25 mg

alphapharm pty ltd - clozapine, quantity: 25 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; povidone; purified talc; colloidal anhydrous silica; magnesium stearate

CLOPINE 100 clozapine 100 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

clopine 100 clozapine 100 mg tablet bottle

pfizer australia pty ltd - clozapine, quantity: 100 mg - tablet, uncoated - excipient ingredients: povidone; lactose monohydrate; magnesium stearate; sodium starch glycollate; microcrystalline cellulose - indications as at 22 october 2003: treatment with clopine is indicated only in people with treatment-resistant schizophrenia, ie. people with schizophrenia who are non-responsive to, or intolerant of other antipsychotic drugs. non-responsiveness is defined as lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

CLOPINE 100 clozapine 100 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

clopine 100 clozapine 100 mg tablet blister pack

pfizer australia pty ltd - clozapine, quantity: 100 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; povidone; lactose monohydrate; magnesium stearate - indications as at 22 october 2003: treatment with clopine is indicated only in people with treatment-resistant schizophrenia, ie. people with schizophrenia who are non-responsive to, or intolerant of other antipsychotic drugs. non-responsiveness is defined as lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

CLOZARIL clozapine 100 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

clozaril clozapine 100 mg tablet blister pack

viatris pty ltd - clozapine, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; maize starch; purified talc; magnesium stearate; povidone - clozaril is indicated in treatment-resistant schizophrenic patients only, i.e. schizophrenic patients who are non-responsive to, or intolerant of other antipsychotic drugs. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

CLOZAPINE MYLAN clozapine 100 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

clozapine mylan clozapine 100 mg tablet blister pack

viatris pty ltd - clozapine, quantity: 100 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; maize starch; purified talc; magnesium stearate; povidone - clozapine mylan is indicated in treatment-resistant schizophrenic patients only, i.e. schizophrenic patients who are non-responsive to, or intolerant of other antipsychotic drugs. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

CLOZAPINE MYLAN clozapine 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

clozapine mylan clozapine 25 mg tablet blister pack

viatris pty ltd - clozapine, quantity: 25 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; colloidal anhydrous silica; povidone; magnesium stearate; purified talc - clozapine mylan is indicated in treatment-resistant schizophrenic patients only, ie. schizophrenic patients who are non-responsive to, or intolerant of other antipsychotic drugs. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

LOZAPINE 100 MG Israel - English - Ministry of Health

lozapine 100 mg

taro international ltd, israel - clozapine - tablets - clozapine 100 mg - clozapine - clozapine - treatment of schizophrenic patients only in cases who are nonresponsive to conventional therapy.

CLOZARIL clozapine tablet United States - English - NLM (National Library of Medicine)

clozaril clozapine tablet

cardinal health - clozapine (unii: j60ar2ikic) (clozapine - unii:j60ar2ikic) - clozapine 100 mg

CLOZARIL clozapine 100mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

clozaril clozapine 100mg tablet bottle

viatris pty ltd - clozapine, quantity: 100 mg - tablet, uncoated - excipient ingredients: purified talc; maize starch; povidone; magnesium stearate; colloidal anhydrous silica; lactose monohydrate - clozaril is indicated in treatment-resistant schizophrenic patients only, i.e. schizophrenic patients who are non-responsive to, or intolerant of other antipsychotic drugs. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two classes of marketed antipsychotic drugs prescribed for reasonable durations. intolerance is defined as the impossibility to achieve adequate benefit with other antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).

CLOZAPINE TABLET 100 mg Singapore - English - HSA (Health Sciences Authority)

clozapine tablet 100 mg

pharmline marketing pte. ltd. - clozapine - tablet - 100 mg - clozapine 100 mg